Project Details
| Short title | MR907-2502 |
|---|---|
| Status | Active |
| Effective start/end date | 17.02.2026 → 16.02.2027 |
Fields of science
- 303031 Tropical medicine
- 303041 Infectious diseases
A phase 2, multicentre, open-label, single arm study to evaluate the effectiveness and safety of rezafungin (as acetate) in the treatment of chronic pulmonary aspergillosis (CPA) in patients with limited treatment options
- Salzer, Helmut (PI)
- Neuböck, Matthias (Researcher)
- Kainz, Sandra (Administration)
- Zaunmair, Pia (Administration)
- Gattringer, Sophie (Administration)
Project: Clinical studies › Clinical Study (Industry project)